Fudan UniversityShanghai, /
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Disclosures:
260 - Consolidative Stereotactic Radiotherapy in Metastatic EGFR-Mutant Non-Small Cell Lung Cancer Receiving First-Line Third-Generation EGFR Tyrosine Kinase Inhibitors: A Prospective Phase II Trial
Tuesday, October 1, 20248:30 AM – 8:40 AM ET